Clinical Trials Directory

Trials / Completed

CompletedNCT01782781

Local Infiltration Analgesia After Abdominal Hysterectomy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Göteborg University · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate traditional analgesic therapy after abdominal hysterectomy with single infiltration of local anesthetics in the surgical area at the end of surgery.

Detailed description

The study is a controlled, double blind, prospective, randomized and performed at Sahlgrenska University Hospital in Goteborg, Sweden. The injectant mixture consists of 300 mg ropivacaine mixed with 30 mg ketorolac and 0.5 mg epinephrine. Total volume of the solution is 156 ml. The normal saline injection is used in the control group in the same manner as in the LIA group. The parameters which would be evaluated are consumption of morphine, pain intensity and side effects. The primary objective is to evaluate whether local infiltration analgesia (LIA) into the operating field will reduce morphine consumption during the first 24 postoperative hours in patients undergoing abdominal hysterectomy (AH). Secondary end-points are pain intensity, incidence of nausea and vomiting, sedation intensity.

Conditions

Interventions

TypeNameDescription
DRUGropivacaine, ketorelac and epinephrineActive group
DRUGPlaceboPlacebo group

Timeline

Start date
2012-11-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2013-02-04
Last updated
2015-01-21

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01782781. Inclusion in this directory is not an endorsement.